Answers are grounded in this paper and cite their sources.
Spore-based probiotics offer important advantages over other probiotics as they can survive the harsh gastric conditions of the stomach and bile salts in the small intestine, ultimately germinating in the digestive tract. A novel clinical trial in 11 ileostomy participants was conducted to directly investigate the presence and germination of the probiotic strain Bacillus subtilis DE111® in the small intestine. Three hours following ingestion of DE111®, B. subtilis spores (6.4 × 10⁴ ± 1.3 × 10⁵ CFU/g effluent dry weight) and vegetative cells (4.7 × 10⁴ ± 1.1 × 10⁵ CFU/g effluent dry weight) began to appear in the ileum effluent. Six hours after ingestion, spore concentration increased to 9.7 × 10⁷ ± 8.1 × 10⁷ CFU/g and remained constant to the final time point of 8 h. Vegetative cells reached a concentration of 7.3 × 10⁷ ± 1.4 × 10⁸ CFU/g at 7 h following ingestion. These results reveal orally ingested B. subtilis DE111® spores are able to remain viable during transit through the stomach and germinate in the small intestine of humans within 3 h of ingestion.
No takes yet. Share an insight, caveat, or question.
Colom et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: